Modified-IgG antibodies that bind transforming growth factor-BETA1 with high affinity, avidity and specificity | Patent Number 11834495

US 11834495 B2
Application Number17717967
Publication NumberUS 20220315649 A1
Pendency1 year, 7 months, 28 days
Filled DateApr 11, 2022
Priority DateMar 4, 2015
Publication DateOct 6, 2022
Expiration DateMar 3, 2035
Inventor/ApplicantsJulie Bird
Huawei Qiu
ExaminesXIE, XIAOZHEN
Art Unit1646
Technology Center1600
Assignments
Sanofi
Current
Sanofi
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.